Zhitong Finance App News, China Biotechnology Service (08037.HK) announced that at the 22nd Japan Neutron Capture Therapy Academic Conference (JSNCT22) held at Kyoto University in Japan, the company's subsidiary, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. published in the form of an oral report the first 10 cases of head and neck cancer patients from Pengbo (Hainan) Boron Neutron Hospital (Pengbo Hainan Hospital) who received boron neutron capture therapy (boron neutron treatment) for the first 10 cases of head and neck cancer followed up three months (90 days) after treatment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.